Nifty Pharma Today: Index Falls 0.68% to 26,478.10

Quick sector takeaways

• Nifty Pharma ended 180.55 points lower, down 0.68%, at 26,478.10 on 4 September 2026.
• The index finished below its previous close of 26,658.65 after trading between 26,461.40 and 26,695.00 during the session.
• Market breadth was negative: 16 of 20 tracked pharma stocks declined, while four advanced and none were unchanged.
• JB Chemicals & Pharmaceuticals, Zydus Lifesciences, Mankind Pharma and Divi’s Laboratories were among the key drags; Aurobindo Pharma and Gland Pharma were notable gainers. The next-session focus remains on whether breadth improves from the day’s 4:16 advance-decline split.

Nifty pharma today reflected broad-based pressure at the close, with the sector index finishing near its intraday low. The 0.68% decline made Nifty Pharma the top losing sector index among the configured sector indices in this session.

Nifty Pharma today: end-of-session sector wrap

Nifty Pharma closed at 26,478.10, down 180.55 points from 26,658.65 in the previous session. The index opened at 26,659.55, marginally above the previous close, but ended lower as the session progressed. Its close was only 16.70 points above the day’s low of 26,461.40, while remaining 216.90 points below the intraday high of 26,695.00.

The closing position shows that the sector’s final level was closer to the lower end of its day range. This is an observation of the session’s price path rather than an explanation for the move. For readers tracking nifty pharma today, the key numerical picture is a lower close, a 233.60-point intraday range, and negative participation across most tracked stocks.

Price snapshot

The opening level was 0.90 points above the previous close, and the day high was 36.35 points above the opening print. By the close, however, the index was 181.45 points below its opening level. This sequence places the session’s closing emphasis on the lower end of the range.

Sector ranking

Nifty Pharma was the top losing sector index among the configured Univest sector indices on 4 September 2026. Its 0.68% fall was steeper than the declines recorded by Nifty IT (-0.47%), Nifty Auto (-0.45%), Nifty Mid Select (-0.31%), Nifty FMCG (-0.14%) and Nifty Bank (-0.02%). In contrast, Nifty Financial Services rose 0.49% and Nifty Metal gained 1.07%.

This ranking frames the day’s relative sector performance: pharma finished at the bottom of the configured group. It does not, by itself, establish a cause for the movement, but it does highlight the sector’s relative weakness at the closing bell.

Constituent breadth

The breadth data underlined the index decline. Of 20 display-safe pharma stocks, 16 closed lower and four closed higher, producing an advance-decline ratio of 0.25. There were no unchanged stocks. In other words, every four decliners were matched by one advancer.

Negative breadth was visible across several parts of the index. The result was not confined to one or two names: the broad 16:4 split aligned with the sector index’s 0.68% decline. The four gainers—Aurobindo Pharma, Gland Pharma, Ipca Laboratories and Abbott India—provided selective counter-moves, but they did not alter the overall closing direction.

Heavyweights versus broader participation

The supplied heavyweight basket also closed largely lower. Sun Pharmaceutical Industries fell 0.89% to ₹1,899.00, while Divi’s Laboratories lost 1.62% to ₹9,100.00. Torrent Pharmaceuticals declined 0.99%, Cipla slipped 0.70%, and Dr. Reddy’s Laboratories edged down 0.35%.

The same five names appear in the supplied most-active list. Their shared negative close, alongside broader weakness in 16 stocks, is consistent with the sector index ending lower. Divi’s Laboratories and Dr. Reddy’s Laboratories each finished at their respective day lows, while Sun Pharmaceutical Industries closed near its intraday low.

Key Nifty Pharma stocks

Biggest positive movers

Aurobindo Pharma led the gainers, rising 0.97% to ₹1,653.10 after trading between ₹1,622.60 and ₹1,661.50. Gland Pharma gained 0.84% to ₹2,932.40, with a day range of ₹2,851.10 to ₹2,969.00. Ipca Laboratories advanced 0.47% to ₹1,965.30, while Abbott India rose 0.46% to ₹26,065.00.

These four positive closes represent the constructive portion of the sector breadth. Aurobindo Pharma’s gain was the largest in percentage terms, while Abbott India registered the largest absolute rupee gain among these names, up ₹120.00.

Biggest negative movers

JB Chemicals & Pharmaceuticals was the largest percentage loser, falling 3.87% to ₹2,408.90 from ₹2,506.00. Zydus Lifesciences lost 2.01% to ₹1,120.00. Mankind Pharma declined 1.73% to ₹2,327.90, followed by Divi’s Laboratories at -1.62% and Ajanta Pharma at -1.60%.

JB Chemicals & Pharmaceuticals traded between ₹2,380.00 and ₹2,525.50. Zydus Lifesciences closed at ₹1,120.00, its day low, while Divi’s Laboratories also ended at its day low of ₹9,100.00. These price positions are session observations that add context to the negative closing breadth.

Stocks to watch next session

For the next session, readers can monitor Aurobindo Pharma, Gland Pharma, JB Chemicals & Pharmaceuticals, Zydus Lifesciences, Divi’s Laboratories and Sun Pharmaceutical Industries. These stocks captured both sides of the day’s move: the leading gainers, the largest decliners and a key heavyweight name.

Aurobindo Pharma closed at ₹1,653.10 versus ₹1,637.30 previously, while Gland Pharma ended at ₹2,932.40 versus ₹2,907.90. On the weaker side, JB Chemicals & Pharmaceuticals ended at ₹2,408.90, Zydus Lifesciences at ₹1,120.00 and Divi’s Laboratories at ₹9,100.00. Sun Pharmaceutical Industries closed at ₹1,899.00. Watching how these names trade alongside sector breadth can help contextualise the next Nifty Pharma session.

The constructive case

The constructive evidence lies in the presence of four advancing stocks despite the lower sector close. Aurobindo Pharma, Gland Pharma, Ipca Laboratories and Abbott India all ended in positive territory. Gland Pharma closed above its previous close after opening at ₹2,915.00, and Abbott India ended ₹120.00 higher than its previous close.

The index also remained above its intraday low at the close, finishing 16.70 points higher than 26,461.40. That limited distance does not change the day’s negative outcome, but it records that the index did not close at its absolute low.

The cautious case

The cautious case is defined by the 0.68% sector fall, Nifty Pharma’s position as the top losing configured sector index, and the 16:4 advance-decline split. The index ended 180.55 points below its previous close and 181.45 points below its opening level.

Several prominent supplied names were lower, including Sun Pharmaceutical Industries, Divi’s Laboratories, Torrent Pharmaceuticals, Cipla and Dr. Reddy’s Laboratories. The largest percentage losses were concentrated in JB Chemicals & Pharmaceuticals, Zydus Lifesciences, Mankind Pharma, Divi’s Laboratories and Ajanta Pharma. The closing level’s proximity to the day low is another factual feature for market participants to track.

Univest Insights

The end-of-session picture for nifty pharma today is clear: a lower index close was accompanied by predominantly negative breadth. The sector’s 0.68% decline was modest in absolute percentage terms, yet it was the largest fall among the configured sector indices.

Within the index, the split between gainers and losers was decisive. Four stocks advanced, but 16 declined. That distribution matters because it provides context beyond the headline index number and shows that weakness extended across a substantial portion of the tracked pharma basket.

The supplied heavyweight and most-active names also leaned lower. Sun Pharmaceutical Industries, Divi’s Laboratories, Torrent Pharmaceuticals, Cipla and Dr. Reddy’s Laboratories all closed in negative territory. Meanwhile, Aurobindo Pharma and Gland Pharma stood out as the leading positive movers.

Readers can follow the broader market context through Univest Market View and monitor the sector on the Nifty Pharma screener. For traders and investors, the key signal to watch is…

Published on 4 September 2026 at 4:19 PM IST

Frequently asked questions

What was Nifty Pharma today?

Nifty Pharma closed at 26,478.10 on 4 September 2026, down 180.55 points or 0.68% from its previous close of 26,658.65.

Why was Nifty Pharma the top losing sector index?

Nifty Pharma declined 0.68%, the largest fall among the configured sector indices for the session.

What was the intraday range for Nifty Pharma?

The index traded between a day low of 26,461.40 and a day high of 26,695.00.

How was Nifty Pharma breadth at the close?

Among 20 display-safe stocks, 16 declined and four advanced. No stocks were unchanged.

Which stocks were the biggest Nifty Pharma losers?

JB Chemicals & Pharmaceuticals fell 3.87%, Zydus Lifesciences lost 2.01%, and Mankind Pharma declined 1.73%.

Which stocks gained in Nifty Pharma today?

Aurobindo Pharma gained 0.97%, Gland Pharma rose 0.84%, Ipca Laboratories added 0.47%, and Abbott India advanced 0.46%.